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ABSTRACT
Objectives: Elevated uric acid level is related to a variety of adverse metabolic conditions including gout, obesity, and risk factor for cardiovascular 
diseases. This prospective study designed to assess the serum and urine uric acid level in relation with anthropometric indices in overweight and 
obese undergraduate students at NAU, Nnewi, Nigeria.
Methods: A total of 302 undergraduate students aged between 18 and 40 years were randomly recruited for the present study. They were grouped 
based on their body mass index (BMI) as overweight, obese, and control participants. 132 participants were males, of which 21 were obese, 34 were 
overweight while 77 were normal (control) males. 170 participants were females, of which 56 were obese, 62 were overweight while the remaining 
52 were normal (control) females. Fasting blood and 24 h urine sample were aseptically collected from all the participants for determination of serum 
and urine uric acid.
Results: The study observed significantly higher serum uric acid level in obese and overweight males than female and control counterparts (p=0.000, 
respectively). Urine uric acid level was significantly higher in obese males and females than in their overweight and control counterparts (p=0.000). 
This shows increase production and accumulation of monosodium urate with decreased uric acid excretion which may result in hyperuricemia and 
hyperuricosuria which may result in gout. Serum and urine uric acid levels were significantly higher among age range (26–32) and (33–40) years 
compared with those among age range (18–25) (p<0.05) signifying that uric acid level increases with age. Serum and urine uric acid were significantly 
positively correlated with BMI, waist circumference, and waist hip ratio (p<0.05).
Conclusions: High serum uric acid is a prerequisite for gout and also associated with the metabolic syndrome and risk factors for cardiovascular 
disease. Proper awareness of the implication of hyperuricemia among undergraduate students is necessary.
Keywords: Uric acid, Anthropometric indices, Overweight, Obesity, Undergraduate students.
INTRODUCTION
Uric acid is originated from enzymatic degradation and metabolic 
conversion of exogenous or endogenous purines in the liver and 
intestine. It is excreted in urine through the kidney as the by-product 
of amino acid (purines) metabolism in humans [1]. Uric acid is a weak 
acid with a high dissociation constant and can exist in plasma as the 
monovalent sodium salt in the form of monosodium urate [2]. Some 
studies have indicated that variation in serum uric acid is genetic and 
could be affected by several genes [3-5]. When the saturation threshold 
of uric acid in body fluids (serum or urine) is exceeded, hyperuricemia 
or hyperuricosuria, respectively, occurs. The average urate pool in 
healthy adults is estimated to be 1200 mg with a mean turnover rate 
of 700 mg/day. Hyperuricemia was established as serum uric acid 
level >450 µmol/L for males and >390 µmol/L for females while 
hyperuricosuria was defined as urine uric acid level >1000 mg/24 h 
assuming for normal diets and <600 mg/24 h assuming low purine 
diets [6-8]. Excessive production and accumulation of monosodium 
urate with a reduction in the urinary excretion lead to high level of 
uric acid in body fluids. This results in the formation and continual 
deposition of the crystals in and around the joints and tissues thereby 
causing severe pains and inflammation in the joints and subsequently 
leads to impaired health [9-11]. Elevation of uric acid is associated 
with a variety of metabolic diseases including inflammatory gout, 
hypertension and cardiovascular death, renal disease, atherosclerosis, 
and ischemic heart disease [12-19]. Several modifiable risk factors 
have been linked with hyperuricemia; these include starvation, body 
mass index (BMI), obesity, waist circumference (WC), high purine, and 
fructose-rich diets [20,21]. Serum uric acid may be grossly elevated 
in starvation due to accelerated tissue turnover and reduced renal 
excretion of uric acid [22]. Impaired kidney function leads to impaired 
uric acid excretion in the urine [23].
Uric acid level in body fluid can vary with height, body weight, kidney 
function, and alcohol intake in healthy men [24]. Reports have associated 
elevated serum uric acid levels with BMI and WC [2,19,25]. However, 
Sivakumar et al. reported that serum uric acid was not significantly 
correlated with BMI [2]. BMI is an index of weight and height which 
is used in classifying overweight and obesity in the adult population 
and individuals. Overweight and obesity are defined as abnormal or 
excessive fat accumulation due to excess calorie intake; several authors 
have reported a significant positive association between elevated serum 
uric acid levels, overweight, and obesity [18,26-28]. Obese individuals, 
due to excess calorie intake, get impaired kidney excretion leading to the 
hyperuricemia [29]. The pathogenic factors responsible for the elevated 
uric acid level in obesity have been implicated to lecithin concentration 
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and decreased urinary excretion of its metabolites [30,31]. However, the 
mechanism behind impaired urate excretion in obese individuals and 
its improvement during weight reduction remains to be determined.
The average urate pool in healthy adults is estimated to be 1200 mg 
with a mean turnover rate of 700 mg/day. It has been indicated that 
the level of serum uric acid is lower in women than in men [29,32,33]. 
However, a study has shown that obesity-related hyperuricemia can 
be treated with only appropriate diet therapy without drugs in most 
cases [34]. The present study, therefore, sets to assess the serum and 
urine uric acid levels in relation with anthropometric indices among 
overweight and obese university undergraduate students at Nnamdi 
Azikiwe University Nnewi Campus Nigeria.
METHODS
Study design
This is a cross-sectional prospective study designed to assess the serum 
and urine uric acid levels in relation with anthropometric indices among 
overweight and obese undergraduate students at Nnamdi Azikiwe 
University, College of Health Sciences, Nnewi Campus, Anambra State, 
Nigeria.
Study population
The study population consisted of 302 apparently healthy male and 
female students. They were randomly recruited and grouped based on 
their BMI as obese >30 kgm2, overweight 25–29.9 kgm2, and control 
<25 kg2 [35]. The study was conducted between March and May, 
2017.132 participants were males, of which 21 were obese, 34 were 
overweight while 77 were normal (control) males. 170 participants 
were females of which 56 were obese, 62 were overweight while the 
remaining 52 were normal (control) females.
Inclusion criteria
Apparently healthy adult male and female undergraduate students 
aged between 18 and 40 years were recruited for the study.
Exclusion criteria
Students with any known disease conditions, for example, liver and 
kidney disease diabetics or those taking alcohol, medications that may 
affect the level of uric acid in serum and urine, for example, diuretic. 
Pregnant women and lactating mothers were excluded.
Sample collection
5 ml of blood was collected by venepuncture from the subjects 
following overnight fasting on the morning of completing urine 
collection and dispensed into a plain container for centrifugation 
at 5000 rpm for 5 min. Serum was extracted for the estimation 
of serum uric acid. The samples were refrigerated at −20°C until 
analyzed. 24 h urine specimen was collected aseptically from all 
the participants without dietary regulation except for alcohol and 
medications.
Ethical consideration
Ethical clearance for the study was obtained from the Ethics committee 
of Nnamdi Azikiwe University Teaching Hospital, Nnewi, as well as 
Faculty of Health Science and Technology, College of Health Sciences, 
Nnamdi Azikiwe University, Nnewi Campus Nigeria. The informed 
consent was obtained from the subjects, and their participation was 
voluntary.
Sample processing and storage
The blood sample was withdrawn from the antecubital vein by means 
of sterile plastic syringes into a plain container and was allowed to clot. 
Later, the tubes were centrifuged for 10 min for proper separation of 
the serum. After centrifugation, the serum samples were separated and 
used stored frozen at −20°C until the analysis of serum uric acid. 24 h 
urine sample was collected with the universal container and was stored 
frozen until analysis urine uric acid.
Sample analysis
Estimation of uric acid;
The serum uric acid and urine uric acid levels were measured by the 
uricase method [36].
Principle
Uric acid + O2+ 2H2 uricase Allantoin + CO2 + H2O2
2H2O2 + 4-Aminoantipyrine + DHBS peroxidase  chromogen + 4 H20
Uric acid is converted by uricase into allantoin and hydrogen peroxides. 
The hydrogen peroxide initiates the coupling of 4-aminoantipyrine to 
3,5-dichloro-2-hydroxybenzene sulfonic acid to form the chromogen 
which is measured at 520 nm and which is proportional to the amount 
of hydrogen peroxide generated from uric acid.
Anthropometric measurement
The BMI was calculated by dividing the weight (kg) by height square 
(m2) [37].
WC was measured twice in millimeters, using the smallest 
circumference between the lower ribs and iliac crests. WC <80 cm for 
females and <90 cm for males were defined as the reference values [38]. 
Hip circumference was measured using the greatest circumference 
between the iliac crest at the level of the umbilicus and thigh at the 
level of maximal protrusion of the gluteal muscles at the widest 
circumference. Waist-hip ratio (WHR) was calculated as the ratio of WC 
to hip circumference.
The average of the two measurements for each variable was then used 
in the analyses. Body fat composition was estimated by bioelectrical 
impedance technology (Valhalla Scientific, San Diego, CA).
Statistical analysis
Data generated from the study were subjected to statistical analysis 
using the Statistical Package for the Social Sciences version 20.0. The 
result was expressed as a mean±standard deviation; the statistical 
difference between groups was done using analysis of variance 
(ANOVA) with post hoc (least standard deviation). Pearson’s correlation 
analysis was used for association between variables. The differences 
were considered significant at p<0.05.
RESULTS
The mean BMI was significantly higher in obese males and females 
(30.92±4.90 and 29.18±4.10) when compared with overweight 
(26.71±4.80 and 25.08±3.50) and control (22.89±2.91 and 22.10±3.09), 
and significantly higher in overweight than control participants (P=0.000, 
respectively). Similarly, the WC was significantly higher in obese 
males and females (105 61±12.10 and 94.77±4.32) when compared 
with their overweight (95.12±10.04 and 86.46±9.01) and control 
(76.99±4.11 and 72.69±2.90) counterparts (p=0.000, respectively). The 
mean value of WHR was also significantly higher in obese males and 
females (0.99±0.84 and 0.89±0.07) compared with their corresponding 
overweight (0.90±0.51 and 0.81±0.06) and control (0.78±0.34 and 
0.75±0.04) participants (p=0.000, respectively) (Table 1).
Levels of serum uric acid levels and urine uric acid in obese 
overweight and control male and female participants
When the mean serum uric acid and urine uric acid levels were 
compared among all the participants, the mean serum uric acid level 
in obese and overweight males (382.83±87.64 and 356.63±85.40) was 
significantly higher when compared with obese female (277.78±78.90), 
overweight female (220.80±68.30), control male (289.72± 66.96), and 
control female (193.70±56.83) participants (p=0.000, respectively).
Similarly, the mean urine uric acid level in obese males and females 
(1059.74±399.91 and 1035.22±395.64) was significantly higher when 
compared with overweight female (914.20±351.52), control male 
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The mean serum uric acid level in obese male and female (382.83±87.64 
and 277.78±78.97) was significantly higher when compared with their 
control counterparts (289.72±66.96 and 193.76±56.83) (p=0.000, 
respectively). Similar observation was made in the mean serum uric acid 
level between overweight male (356.63±85.40) control male and female 
(289.72±66.96 and 193.76±56.83) participants (p=0.000, respectively).
The mean urine uric acid level in obese males and females 
(1059.74±399.91 and 1035.22±395.64) was significantly higher when 
compared their corresponding control (886.94±349 and 877.62±291.74) 
participants (p=0.000, respectively). Similar observation was made in 
overweight males (984.60±352.10) when compared with control male 
and female (886.94±349 and 877.62±291.74) participants (p=0.001, 
0.020, and 0.000, respectively). There was a significantly higher mean 
level of serum uric acid in control male (289.72±66.96) when compared 
with the female counterpart (193.76±56.83) (p=0.000) (Table 2).
Levels of serum uric acid and urine uric acid according to age 
ranges
The mean serum uric acid level was significantly higher among the 
age range 26–32 and 33–40 years (289.00±72.33 and 299.10±83.66) 
when compared with participants among the age range 18–25 years 
(238.10±72.69) (p=0.003).
Similarly, the mean urine uric acid level was significantly higher 
among age range 26–32 years (922.50±324.20) and 33–40 years 
(999.40±444.80) when compared with participants within the 
age range of 18–25 years (805.90±82.12) (p=0.000 and 0.003). 
Furthermore, the urine uric acid level was significantly higher among 
the age range 33–40 (999.40±444.80) when compared with those 
within 26–32 (922.50±324.20) years (p=0.040) (Table 3).
Correlation of serum uric acid and urine uric acid with the 
anthropometric parameters
Serum uric acid was significantly positively correlated with age, BMI, 
WC, and WHR, (r=0.289, 0.313, 0.431, 0.326, and 0.265, p=0.014, 0.032, 
0.011, 0.029, and 0.041, respectively). Similarly urine uric acid was 
significantly positively correlated with age, BMI, and WC, (r=0.211, 
0.351, and 0.549, p=0.008, 0.021, and 0.000, respectively) (Table 4).
DISCUSSION
Participants in this study were classified based on their BMI into 
obese (>30), overweight (25.0–29.9 kg/m2), and normal control 
subjects (18.5–24.9 kg/m2) according to the WHO classification of 
body mass index [35]. The present study observed significantly higher 
serum uric acid in obese and overweight males when compared with 
their female counterparts and controls. This is consistent with the 
other reports [19, 39,40]. This is an indication of increase formation 
and deposition of monosodium urate crystals in and around joints 
suggesting the future risk of development of gout [10] as well as other 
adverse conditions associated with hyperuricemia [12-18]. Increased 
serum uric acid levels in these participants may also be due to reduced 
renal clearance and excessive secretion and production of uric acid 
by the adipose tissue through xanthine oxidoreductase. Several 
researchers have also observed elevated levels of serum and urine 
uric acid level in both men and women [41-43]. In women, the sexual 
dimorphism in serum uric acid level was thought to be related to higher 
renal clearance of urate, possibly due to their higher plasma estrogen 
levels [41,44,45]. However, our study observes that obese male and 
female participants had significantly higher serum uric acid than the 
control female. This is similar to the report of Oyama et al. [46]. Our 
study also observed significantly higher serum and urine uric acid levels 
in males when compared with females. This shows that variation on the 
uric acid level is sex-dependent. Increase serum uric acid in apparently 
healthy males than females have been previously reported [5,41,47]. 
There have been reports of overwhelming increases in the prevalence 
of gout disease globally [42,48,49]. Gout has been previously linked 
with some metabolic disorders including coronary heart disease and 
cardiovascular death in females [50,51] while the risk factors for gout 
include obesity, metabolic Syndrome WHR, renal disease, and use of 
medications [52-56]. However, variation in body weight can modify the 
various risk factors for metabolic syndrome [57]. Previous reports have 
reported an increased prevalence of obesity in female undergraduate 
students [58,59]. Obesity is characterized by excess body fat, and this 
excess body fat induces a variety of cardiovascular disease risk factors 
such as insulin resistance, hypertension, dyslipidemia, and endothelial 
dysfunction [60].
In the present study, participants were grouped into age ranges 18–
25 years, 26–32 years, and 33–40 years. Comparison of the serum and 
urine uric acid levels among participants within age range 26–32 and 
33–40 years were significantly higher when compared with age range 
18–25 years and significantly higher in age range 33–40 than 26–
32 years. This study revealed that uric acid level tends to increase with 
age. This is consistent with previous reports [41,61].
The present study showed that SUA and UUA were positively correlated 
with age, BMI, WC, and WHR. These findings are in line with previous 
reports [5,62,63]. The WC and WHR are measures of visceral adiposity 
and body fat accumulation [64]. The study has shown that excess 
free fatty acid production as a result of increased in visceral fat might 
indirectly affect uric acid production through common pathways 
involving nicotinamide adenine dinucleotide phosphate [65]. Increased 
visceral fat might contribute to decreased uric acid excretion this can 
result to metabolic syndrome as well as other cardiovascular risk 
factors [66,67]. It has been indicated that WC is stronger biomarker for 
obesity than BMI. Elevated WC and BMI are associated with increased 
insulin resistance, and this decreases the kidney excretion of uric acid 
thereby increasing its concentration [2]. The elevated and significant 
positive correlation between uric acid and WC was also attributed to 
increase concentration of leptin with reduced urinary excretion [31,68] 
thereby leading to increased uric acid concentration in obese 
individuals.
CONCLUSION
The study concludes that there was significantly higher serum uric 
acid level in obese and overweight male than their female counterparts 
and controls. The mean urine uric acid level was also significantly 
higher in obese male and females than in their overweight and 




(males, n=34, females, n=62)
Obese
(males, n=21, females, n=56)
Control 
(males, n=77, females, n=52)
p value
Age (years) males 22.99±1.29 22.08±2.44 22.70±1.06 0.165
Age (years) Females 21.47±2.40 21.81±1.94 21.67±3.01 0.131
BMI (kg/m2) males 26.71±4.80 30.92±4.9 22.89±2.91 0.000
BMI (kg/m2) females 25.08±3.50 29.18±4.1 22.10±3.09 0.000
WC (cm) males 95.12±10.04 105 61±12.10 76.99±4.11 0.000
WC (cm) females 86.46±9.01 94.77±4.32 72.69±2.90 0.000
WHR males 0.90±0.51 0.99±0.84 0.78±0.34 0.000
WHR females 0.81±0.06 0.89±0.07 0.75±0.04 0.000
p<0.05=Significant. Data were expressed as mean±SD. SD: Standard deviation, WHR: Waist-hip ratio, BMI: Body mass index, WC: Waist circumference
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control counterparts. This shows that the participants might be 
predisposing to hyperuricemia and hyperuricosuria which could lead 
to gout and subsequently results in other adverse conditions such as 
atherosclerosis, metabolic syndrome, as well as cardiovascular diseases. 
Serum and urine uric acid levels were significantly higher among the 
age range 26–40 years. The serum and urine uric acid levels were 
significantly positively correlated with age, BMI, WC, and WHR. This 
shows that elevated uric acid level is age- and sex-dependent. Proper 
awareness of the prevalence of hyperuricemia is necessary. Importance 
of good dietary regimens and physical exercise is highly advocated for 
weight reduction among university undergraduates in the study area to 
minimize the risk of gout.
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